SS

Sarfaraj Sadikbhai Patel

Active Director Director DIN 11199983
DIN 11199983 First appointment Jul 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Sarfaraj Sadikbhai Patel

Data last updated:

Sarfaraj Sadikbhai Patel is a Director at Ascleplus Pharma Private Limited (since 2025). The company operates in Pharma.

DIN 11199983
Primary Designation Director
Industry Pharma
First Appointment 17 Jul 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ascleplus Pharma Private Limited U46691GJ2025PTC165203
Director17 Jul 20252025Active

Board colleagues of Sarfaraj Sadikbhai Patel

NameDINCompanyDesignation
Patel Maiz Sarafraz11199984Ascleplus Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Ascleplus Pharma Private Limited
Premium access

Shareholding and investment profile for Sarfaraj Sadikbhai Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sarfaraj Sadikbhai Patel

Sarfaraj Sadikbhai Patel currently holds 1 directorship: Ascleplus Pharma Private Limited (Director, since 17 Jul 2025).

Sarfaraj Sadikbhai Patel was first appointed on 17 Jul 2025 as Director at Ascleplus Pharma Private Limited.

The current boards of Sarfaraj Sadikbhai Patel's companies include Patel Maiz Sarafraz (Ascleplus Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available